Cardioinhibitory Reflex Syncope. Permanent Pacemaker Therapy or Cardioneuroablation?

Reflex syncope is the most common form of syncope. It can lead to injuries and affect quality of life. Nonpharmacological and medical therapies have limited effectiveness. In certain patients, cardiac pacing seem to be beneficial. More recently cardioneuroablation (CNA) has emerged as a novel therapy for reflex syncope. The investigators aim to determine whether CNA is more effective than cardiac pacing at reducing the rate of cardioinhibitory-type reflex syncope.

NCT Number	NCT05855603
Lead Sponsor	Institut d'Investigació Biomèdica de Bellvitge
Conditions	Reflex Syncope
Enrollment	90 participants
Start Date	2023-11-22
Primary Completion	2026-11-22 (estimated)
Study Completion	2027-02-22 (estimated)
Updated on ClinicalTrials.gov	2024-01-25